Skip to content

Search drugs, substances, diseases …

Drugs Diseases Magazine Substances About us

🇩🇪DeutschlandDE 🇦🇹ÖsterreichAT 🇨🇭SchweizCH (DE)🇨🇭SuisseCH (FR)🇵🇹PortugalPT 🇪🇸EspañaES 🇳🇱NederlandNL 🇮🇹ItaliaIT 🇫🇷FranceFR

Drugs Diseases Magazine Substances About us

Choose country

🇩🇪Deutschland 🇦🇹Österreich 🇨🇭Schweiz 🇨🇭Suisse 🇵🇹Portugal 🇪🇸España 🇳🇱Nederland 🇮🇹Italia 🇬🇧UK 🇫🇷France

medikamio
Manufacturers
Drugs by Glaxo Group Ltd

Manufacturers

Drugs by Glaxo Group Ltd

1 drugs for which Glaxo Group Ltd holds the marketing authorisation in UK.

Most frequent active substances

Ofatumumab

Advertisement

Arzerra 1,000 mg concentrate for solution for infusionOfatumumab · Glaxo Group Ltd

Advertisement

Advertisement

Your personal medication assistant

Browse our extensive database of medications from A-Z, including effects, side effects, and dosage.

All active ingredients with their effects, applications, and side effects, as well as the medications they are contained in.

Symptoms, causes, and treatments for common diseases and injuries.

All marketing authorisation holders with drugs in UK, alphabetically.

The ATC classification orders drugs by organ system and mechanism of action.

Quick Links

Home Magazine About us

Quick Links

Imprint Privacy TOS

The presented content does not replace the original package insert of the medication, especially regarding the dosage and effects of individual products. We cannot assume liability for the accuracy of the data, as the data has been partially converted automatically. Always consult a doctor for diagnoses and other health-related questions.

© 2026 medikamio